Concepedia

Fotis Drakopanagiotakis

FD

Statistics

Publications

3

Citations

532

H-Index

3

Active since

2012

Affiliations

Sismanoglio General Hospital(Current)

Fotis Drakopanagiotakis is an author at Sismanoglio General Hospital specializing in pharmacotherapy, medicine, and cell signaling.

Top concepts

MedicinePharmacotherapyCell BiologyCytoskeletonPharmacologyCell SignalingPulmonary DiseasePulmonary FibrosisPulmonary MedicineSignal Transduction

Publications per year

2012–2021

3

Publications

3

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

Αrgyris Τzouvelekis, Paschalis Ntolios, Andreas Karameris et al. · BMC Research Notes · 2012 · 29 citations · Full text

Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system

M. D. Kramer, Philipp Markart, Fotis Drakopanagiotakis et al. · Cellular Signalling · 2019 · 13 citations

Signal Transduction, Medicine, Mechanism Of Action +8

1–3 of 3